Quantitative trait loci and candidate genes regulating HDL cholesterol: A murine chromosome map

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 9, 2002, Pages 1390-1401

  Wang, Xiaosong ^a   Paigen, Beverly ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

Atherosclerosis; Cholesterol; High density lipoproteins; Mouse models; Quantitative trait loci

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROSCLEROSIS; CHROMOSOME MAP; CYTOGENETICS; GENE CONTROL; GENE IDENTIFICATION; GENETIC MARKER; GENOMICS; HUMAN; HUMAN GENOME; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; CHOLESTEROL, HDL; CHROMOSOME MAPPING; GENES, REGULATOR; GENETIC MARKERS; HUMANS; MICE; QUANTITATIVE TRAIT, HERITABLE;

EID: 0036738377     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000030201.29121.A3     Document Type: Review

References (100)

1. HDL the inflammatory response induced by LDL-derived oxidized phospholipids
2. High density lipoproteins and arteriosclerosis: Role of cholesterol efflux and reverse cholesterol transport
3. Genes influencing HDL metabolism: New perspectives and implications for atherosclerosis prevention
4. High-density lipoprotein: Gene-based approaches to the prevention of atherosclerosis
5. Mapping mendelian factors underlying quantitative traits using RFLP'linkage maps
6. Transgenic animals with altered high-density lipoprotein composition and functions
7. Structure, function and regulation of the ABC1 gene product
8. Quantitative trait loci that regulate plasma lipid concentration in hereditary obese KK and KK-Ay mice
9. Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model: Interactions between lipoprotein metabolism, autoimmune disease, and atherogenesis
10. Recombinant inbred strains: Use in gene mapping
11. Advanced intercross lines, an experimental population for fine genetic mapping
12. The roads from phenotypic variation to gene discovery: Mutagenesis versus QTLs
13. From QTL to gene: The harvest begins
14. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
15. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol
16. Variation in susceptibility to atherosclerosis among inbred strains of mice
17. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H
18. Diet-induced disease: Gallstones, atherosclerosis, and plasma lipids
19. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H
20. Atherosclerosis and plasma and liver lipids in nine inbred strains of mice
21. Genetic analysis of the difference in diet-induced atherosclerosis between the inbred mouse strains SM/J and NZB/BINJ
22. Complex genetic control of HDL levels in mice in response to an atherogenic diet: Coordinate regulation of HDL levels and bile acid metabolism
23. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice
24. Genetic factors in lipoprotein metabolism: Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach
25. Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/EixC57BL/6J)
26. Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice
27. ATH-3, a new gene for atherosclerosis in the mouse
28. Plasma high-density lipoproteins and atherosclerosis
29. High-density lipoprotein subclasses and apolipoprotein A-I
30. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice
31. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV
32. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV
33. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
34. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis
35. The impact of phospholipid transfer protein (PLTP) on HDL metabolism
36. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
37. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio
38. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency
39. Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains
40. Plasma phospholipid transfer protein: Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL
41. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice
42. A novel endothelial-derived lipase that modulates HDL metabolism
43. Cloning of a unique lipase from endothelial cells extends the lipase gene family
44. An inventory of the human ABC proteins
45. Common and rare ABCAI variants affecting plasma HDL cholesterol
46. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
47. The gene encoding ATP-binding cassette transporter I is mutated in Tangier disease
48. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
49. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
50. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
51. ABCAI overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice
52. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1
53. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse
54. Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice
55. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
56. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: A murine gallstone map
57. ABCC6 gene polymorphism associated with variation in plasma lipoproteins
58. Charting the fate of the "good cholesterol": Identification and characterization of the high-density lipoprotein receptor SR-BI
59. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages
60. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
61. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol
62. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
63. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene
64. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse
65. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics
66. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population
67. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL
68. CD36 does not play a direct role in HDL or LDL metabolism
69. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
70. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
71. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
72. ABC1 gene expression and ApoA-Imediated cholesterol efflux are regulated by LXR
73. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
74. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages: A transcriptional role for specific oxysterols
75. The RXR heterodimers and orphan receptors
76. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
77. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
78. CLAI/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors
79. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
80. Troglitazone directly increases HDL cholesterol levels
81. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: Pleiotropic effects on CD36 expression and HDL
82. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
83. Activation of PPARdelta alters lipid metabolism in db/db mice
84. Human pedigree-based quantitative-trait-locus mapping: Localization of two genes influencing HDL-cholesterol metabolism
85. Strong evidence for linkage of high density lipoprotein cholesterol (HDL-C) concentrations to a genetic location on chromosome 9p in Mexican Americans
86. Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23
87. Genome-wide screen for quantitative trait loci (QTLs) influencing lipid levels in a founder population
88. A locus influencing total serum cholesterol on chromosome 19p: Results from an autosomal genomic scan of serum lipid concentrations in Pima Indians
89. Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study
90. Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) blood pressure study
91. Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans
92. Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: Evidence for linkage of triglyceride levels to chromosome 19q
93. A comprehensive linkage analysis for myocardial infarction and its related risk factors